Amarin Corp Plcuk (AMRN) Change in Acquisitions & Divestments (2020 - 2026)

Amarin Corp Plcuk (AMRN) posted quarterly Change in Acquisitions & Divestments of $42.5 million for Q1 2026, down 22.73% YoY from $55.0 million in Q1 2025, and down 9.58% sequentially from $47.0 million in Q4 2025.

Amarin Corp Plcuk (AMRN) Change in Acquisitions & Divestments (2020 - 2026) Analysis & Trends

Amarin Corp Plcuk has disclosed Change in Acquisitions & Divestments across 7 years of filings, most recently posting $42.5 million for Q1 2026.

  • In Q1 2026, Change in Acquisitions & Divestments fell 22.73% year-over-year to $42.5 million; the TTM figure through Mar 2026 stood at $196.8 million (down 12.84% YoY), while the FY2025 annual figure was $209.3 million, down 10.09% from the prior year.
  • Change in Acquisitions & Divestments eased to $42.5 million in Q1 2026, from $47.0 million in the prior quarter.
  • Over the last five years, Change in Acquisitions & Divestments for AMRN reached as high as $113.2 million in Q1 2022 and fell as low as $16.9 million in Q4 2022.
  • The 5-year median for Change in Acquisitions & Divestments is $54.2 million (2022), against an average of $54.8 million.
  • Annual changes were most pronounced in 2022 — Change in Acquisitions & Divestments plunged 79.42% — and 2024, when it soared 88.38%.
  • A 5-year view of Change in Acquisitions & Divestments shows it stood at $16.9 million in 2022, then soared by 72.19% to $29.1 million in 2023, then jumped by 61.45% to $47.0 million in 2024, then gained by 0.0% to $47.0 million in 2025, then slipped by 9.58% to $42.5 million in 2026.
  • According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $42.5 million, $47.0 million, and $57.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Amarin Corp Plcuk 5.17 Bn 5.00 Bn 17.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 42.50 Mn
Mar 31, 2026 42.50 Mn
Dec 31, 2025 47.00 Mn
Dec 31, 2025 47.00 Mn
Sep 30, 2025 57.00 Mn
Sep 30, 2025 57.00 Mn
Jun 30, 2025 50.30 Mn
Jun 30, 2025 50.30 Mn
Mar 31, 2025 55.00 Mn
Mar 31, 2025 55.00 Mn
Dec 31, 2024 47.00 Mn
Dec 31, 2024 47.00 Mn
Sep 30, 2024 52.80 Mn
Sep 30, 2024 52.80 Mn
Jun 30, 2024 71.00 Mn
Jun 30, 2024 71.00 Mn
Mar 31, 2024 62.00 Mn
Mar 31, 2024 62.00 Mn
Dec 31, 2023 29.11 Mn
Dec 31, 2023 29.11 Mn